Disrupting SARS-CoV-2 Nucleocapsid Phase Separation with GCG
2026-05-13
This study demonstrates that the SARS-CoV-2 nucleocapsid (N) protein undergoes RNA-triggered liquid–liquid phase separation (LLPS), which is essential for viral replication. The polyphenol (-)-gallocatechin gallate (GCG) disrupts this LLPS, highlighting a novel mechanism for antiviral intervention targeting protein–RNA condensates.
Mechanistic Insights into Gepotidacin and DNA Gyrase Inhibit
2026-05-13
This article examines the mechanistic and structural innovations uncovered by Gibson et al. in their study of gepotidacin's action against Staphylococcus aureus DNA gyrase. The findings reveal a unique single-stranded DNA cleavage mechanism distinct from fluoroquinolones, providing a new avenue for antibiotic design and resistance management.
Escitalopram (Lexapro): Mechanism, Selectivity, and Research
2026-05-12
Escitalopram, a selective serotonin reuptake inhibitor (SSRI) and the S-(+)-enantiomer of citalopram, is a benchmark compound for antidepressant research. Its high affinity for the serotonin transporter and negligible activity at noradrenaline and dopamine transporters make it a precision tool for dissecting serotonergic pathways. This article details its mechanism, evidence, protocol parameters, and clarifies common misconceptions.
Fulvestrant (ICI 182,780): Mechanistic Precision for Transla
2026-05-12
This thought-leadership article explores Fulvestrant (ICI 182,780) as an advanced ER antagonist, integrating mechanistic insights on MDM2 degradation, apoptosis induction, and ER signaling disruption in breast cancer models. We bridge foundational molecular evidence with actionable strategies for translational researchers, highlight competitive tool selection, and contextualize immune-ER stress interactions. Drawing on APExBIO’s validated formulation and recent landmark studies, we offer strategic protocols and a visionary outlook for ER-positive breast cancer research.
Puromycin dihydrochloride: Selection and Translation Assays
2026-05-11
Puromycin dihydrochloride is a well-established aminonucleoside antibiotic used to inhibit protein synthesis and select for cell lines expressing the pac gene. It is most suitable for workflows requiring robust, reproducible selection pressure or translational process analysis in both prokaryotic and eukaryotic systems. Do not use in experiments where non-specific cytotoxicity or off-target effects on translation must be rigorously excluded.
Human iPSC-Derived Sensory Neurons Model HSV-1 Latency and R
2026-05-11
This study establishes a robust protocol for differentiating human inducible pluripotent stem cells into sensory neurons and validates their use as a model for latent infection and reactivation of herpes simplex virus 1. The findings offer a scalable human system to investigate the mechanisms underlying HSV-1 latency, advancing research beyond animal models.
Viral Induction of RIPK3 Degradation Shapes Host Inflammatio
2026-05-10
Liu et al. reveal that certain orthopoxviruses deploy a viral protein (vIRD) that co-opts the host SCF ubiquitin ligase machinery to target RIPK3 for proteasome-mediated degradation, suppressing necroptosis and modulating virus-induced inflammation. These findings clarify a crucial mechanism of viral immune evasion with implications for antiviral research and ubiquitin-proteasome pathway analysis.
Targeted SPP1 Inhibition in TAMs: A New Direction for Tumor
2026-05-09
This article examines a recent study that identifies and validates small molecule inhibitors targeting SPP1-high tumor-associated macrophages (TAMs), leading to significant tumor regression in murine models. The findings establish a new paradigm for modulating the tumor microenvironment via macrophage phenotype reprogramming, with practical implications for cancer immunotherapy development.
EZH2-Mediated Autophagy Inhibition Drives Neuropathic Pain A
2026-05-09
This study reveals that upregulation of EZH2 in anterior cingulate cortex microglia intensifies neuropathic pain after brachial plexus avulsion by suppressing autophagy via the mTOR pathway. The findings clarify a mechanistic link among epigenetic regulation, neuroinflammation, and autophagy, offering new directions for pain management research.
Icariin Targets PDE5A to Enhance Spermatogonial Stem Cell DN
2026-05-08
This study identifies Icariin as a regulator of spermatogonial stem cell (SSC) proliferation and DNA integrity via direct targeting of PDE5A. These findings clarify a molecular pathway relevant to male fertility, offering mechanistic insight into SSC fate and potential therapeutic strategies.
Virus-Mimicking Nanoparticles Enable Extrahepatic mRNA Deliv
2026-05-07
This study introduces a self-assembling, enveloped virus-mimicking particle (EVMP) platform for precise extrahepatic delivery of mRNA, overcoming the hepatic tropism limitations of conventional lipid nanoparticles. The modular design achieves high-efficiency transfection in lung and spleen tissues, with robust biosafety and translational potential for mRNA therapeutics.
Gamma-linolenic Acid (GLA): Novel Anti-Inflammatory Insights
2026-05-07
Explore the advanced anti-inflammatory mechanisms and translational applications of gamma-linolenic acid (GLA), an omega-6 polyunsaturated fatty acid. This cornerstone article reveals new scientific depth and practical protocols, establishing a distinct perspective on GLA’s role in inflammation and disease modeling.
RNA Pol II Inhibition Triggers Apoptosis via Active Signalin
2026-05-06
Harper et al. (2025) reveal that inhibiting RNA polymerase II (Pol II) activates cell death through a regulated apoptotic pathway, independent of loss of gene transcription. This paradigm-shifting insight highlights the importance of Pol II protein integrity and signaling in cellular fate control, with implications for understanding anticancer drug mechanisms.
A Tunable Human Intestinal Organoid System: Balancing Renewa
2026-05-06
This study introduces a human intestinal organoid culture system that achieves a controlled balance between stem cell self-renewal and differentiation using small molecule modulators. The approach enables scalable, high-diversity organoid cultures, advancing research in development, disease modeling, and high-throughput applications.
Chloramphenicol in Plasmid Selection: Workflows & Resistance
2026-05-05
Harnessing Chloramphenicol (2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide) from APExBIO, researchers achieve superior plasmid selection and resistance monitoring. This article translates recent findings on multidrug resistance and plasmid gene dynamics into actionable protocols and troubleshooting tips.
462 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page